Answers are grounded in this paper and cite their sources.
Retrospective cohort demonstrates lower blood transfusion rates in delayed compared to immediate autologous breast reconstruction.
Background: Blood loss is a critical component of all surgical procedures. Excess blood loss may require blood transfusion and increase the risk of complications after autologous breast reconstruction. Methods: Retrospective cohort of 264 consecutive autologous breast reconstruction patients between July 2017 and June 2022. Patients were stratified by reconstruction timing and bilateral vs. unilateral reconstruction. Post-operative hemoglobin reduction and transfusion incidence were the primary outcomes of interest. Results: Average preoperative hemoglobin (12.6g/dl) was equivalent among all groups. Comparing bilateral immediate (n=77) and delayed (n=50) patients, immediate reconstructions had greater postoperative hemoglobin losses (-3.26 vs. -1.98 g/dl, p<0.01) and higher transfusion rates (14% vs. 2.0%, p=0.02). Comparing unilateral immediate (n=99) and delayed (n=38) patients, immediate reconstructions had greater hemoglobin losses (-2.60 vs. -1.41 g/dl, p<0.0001) and higher transfusion rates (12.1% vs 0.0% p=0.03). Using regression analysis controlling for confounding variables and intra-operative resuscitation risk factors for blood transfusion requirement were post mastectomy radiation therapy requirement (OR 10.3, p<0.01) and vascular disease (OR 14.5, p=0.02). Unilateral reconstruction was protective from requiring transfusion (OR 0.20, p=0.03). Increasing BMI was protective, and with each increasing unit of BMI transfusion requirement incidence decreased by 12.3% (p=0.04). Transfusion was not associated with flap thrombosis or flap loss. Conclusion: Compared to immediate autologous breast reconstruction, a staged approach to both unilateral and bilateral patients can help minimize the risk of transfusion requirement. These factors as well as additional modifiable and non-modifiable risk factors should be considered when determining timing of autologous breast reconstruction for a patient.
No takes yet. Share an insight, caveat, or question.
DeVito et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: